Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88774513 | 8877451 | 3 | F | 20120101 | 20120618 | 20120426 | 20130107 | PER | PHEH2012US002970 | NOVARTIS | 36.00 | YR | F | N | 68.00000 | KG | 20121205 | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88774513 | 8877451 | 1 | PS | GILENYA (FTY) CAPSULE, 0.5MG | 1 | ORAL | 22527 | 0.5 | MG | QD | |||||||||
| 88774513 | 8877451 | 2 | C | MULTI MAX | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88774513 | 8877451 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88774513 | 8877451 | Dry eye | |
| 88774513 | 8877451 | Eyelid disorder | |
| 88774513 | 8877451 | Fungal infection | |
| 88774513 | 8877451 | Rash | |
| 88774513 | 8877451 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 88774513 | 8877451 | CSM |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88774513 | 8877451 | 1 | 20110606 | 0 |